chr8-97775782-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000445593.6(LAPTM4B):c.46C>T(p.Leu16Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000102 in 1,564,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L16L) has been classified as Benign.
Frequency
Consequence
ENST00000445593.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAPTM4B | ENST00000445593.6 | c.46C>T | p.Leu16Phe | missense_variant | Exon 1 of 7 | 1 | ENSP00000402301.2 | |||
LAPTM4B | ENST00000619747.1 | c.46C>T | p.Leu16Phe | missense_variant | Exon 1 of 7 | 1 | ENSP00000482533.1 | |||
LAPTM4B | ENST00000521545.7 | c.-228C>T | upstream_gene_variant | 1 | NM_018407.6 | ENSP00000428409.1 | ||||
LAPTM4B | ENST00000517924.5 | c.-228C>T | upstream_gene_variant | 5 | ENSP00000429868.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151966Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 177932 AF XY: 0.00
GnomAD4 exome AF: 0.00000991 AC: 14AN: 1412414Hom.: 0 Cov.: 39 AF XY: 0.00000714 AC XY: 5AN XY: 700732 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151966Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74224 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.46C>T (p.L16F) alteration is located in exon 1 (coding exon 1) of the LAPTM4B gene. This alteration results from a C to T substitution at nucleotide position 46, causing the leucine (L) at amino acid position 16 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at